In PointofLaw.com's new Featured Column, our friend Richard Epstein responds to Dr. Arnold Relman's harsh review of his book Overdose in a recent New Republic. Relman is at Harvard and a former editor of the New England Journal of Medicine, but his understanding of basic economics is, shall we say, lacking.

Read the entire column for a penetrating look at the pharmaceutical industry, including regulatory and litigation issues.

(Cross-posted as a Spotlight feature on MI's Medical Progress Today.)